Preferred Name |
eletriptan |
|
Synonyms |
UK 166,044 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C115647 |
|
altLabel |
UK 166,044 (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole UK-166044 Relpax eletriptan hydrobromide 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide UK-116044-04 UK-166,044 UK 166044 UK-116,044-04 |
|
cui |
C4307738 C0759932 C1171655 C0759933 C1178489 |
|
HM |
D014363 D011759 |
|
Inverse of RB |
M41W832TA3 22QOO9B8KI 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19981130 |
|
MeSH Frequency |
164 |
|
MMR |
20161103 |
|
notation |
C115647 |
|
PA |
D017366 |
|
PI |
*INDOLES (1998-2005) |
|
prefLabel |
eletriptan |
|
RR |
M41W832TA3 |
|
SC |
1 |
|
Scope Statement |
5-HT(1B/1D) receptor agonist; structure in first source |
|
SRC |
Naunyn Schmiedebergs Arch Pharmacol 1998 Aug;358(2):212-9 |
|
TERMUI |
T327677 T000911251 T000911250 T462344 T000911252 T327681 T327678 T327679 T624019 T327680 T000911249 T327676 |
|
TH |
US MX NLM (2004) UK FDA SRS (2013) FDA SRS (2017) USAN (19XX) INN (19XX) DE AU NLM (1998) NLM (2017) FR |
|
tui |
T109 T121 |